Markus Daniel Lacher

Title: Innovations in Cancer Treatment by Markus Daniel Lacher

Introduction

Markus Daniel Lacher is a notable inventor based in Redwood City, CA, who has made significant contributions to the field of cancer treatment. His work focuses on developing whole-cell cancer vaccines, which represent a promising approach to combating various forms of cancer.

Latest Patents

Lacher holds a patent for "Whole-cell cancer vaccines and methods for selection thereof." This invention provides a modified human cancer cell that includes a recombinant polynucleotide encoding an allele of a human leukocyte antigen gene. The patent outlines methods for selecting a whole-cell cancer vaccine for patients with cancer and describes techniques for treating cancer using these vaccines. Additionally, it offers a method for determining the HER2 status of a cell, along with compositions and kits related to the invention. Lacher's innovative approach has the potential to enhance cancer treatment options significantly.

Career Highlights

Markus Daniel Lacher is associated with Briacell Therapeutics Corp., a company dedicated to advancing cancer therapies. His work at Briacell has positioned him as a key player in the development of novel cancer treatments.

Collaborations

Lacher collaborates with esteemed colleagues such as Joseph Paul Wagner and Charles Louis Wiseman, who contribute to the research and development efforts at Briacell Therapeutics Corp. Their combined expertise fosters an environment of innovation and progress in cancer treatment.

Conclusion

Markus Daniel Lacher's contributions to the field of cancer treatment through his innovative patents and collaborative efforts highlight the importance of research in developing effective therapies. His work continues to pave the way for advancements in cancer care.